You are here »
Medical Solutions » Major Brands » Mirvaso
MIRVASO (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older.
Growing a responsible dermatological community
Discover some of the positive initiatives we are involved in across the world
We are committed
Avenue Gratta-Paille 2
CH - 1018 Lausanne